2024    2023    2022    2021    2020    2019    2018    2017    2016   

2017

Articles

41 - 

The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13

Pauline Hascoet, Franck Chesnel, Florence Jouan, Cathy Le Goff, Anne Couturier et al.

Oncotarget, 2017, 8 (44), pp.75989-76002.

DOI : https://doi.org/10.18632/oncotarget.18376

Pubmed : 29100286

 

42 - 

Actomyosin-generated tension on cadherin is similar between dividing and non-dividing epithelial cells in early Xenopus laevis embryos

Gaëtan Herbomel, Guillaume Hatte, Julien Roul, Sergi Padilla-Parra, Jean-Pierre Tassan et al.

Scientific Reports, 2017, 7 (1), pp.45058.

DOI : https://doi.org/10.1038/srep45058

Pubmed : 28327558

 

43 - 

An in vivo reporter assay for sRNA-directed gene control in Gram-positive bacteria: identifying a novel sRNA target in Staphylococcus aureus

Lorraine Ivain, Valérie Bordeau, Alex Eyraud, Marc Hallier, Stéphane Dreano et al.

Nucleic Acids Research, 2017, Nucleic Acids Research, 45 (8), pp.4994-5007.

DOI : https://doi.org/10.1093/nar/gkx190

Pubmed : 28369640

 

44 - 

An exome sequencing based approach for genome-wide association studies in the dog

Bart J. G. Broeckx, Thomas Derrien, Stephanie Mottier, Valentin Wucher, Edouard Cadieu et al.

Scientific Reports, 2017, 7 (1), pp.15680.

DOI : https://doi.org/10.1038/s41598-017-15947-9

Pubmed : 29142306

 

45 - 

Promises and limitations of nanoparticles in the era of cell therapy: Example with CD19-targeting chimeric antigen receptor (CAR)-modified T cells

Helene Jakobczyk, Flavien Sciortino, Soizic Chevance, Fabienne Gauffre, Marie-Bérengère Troadec et al.

International Journal of Pharmaceutics, 2017, 532 (2), pp.813-824.

DOI : https://doi.org/10.1016/j.ijpharm.2017.07.075

Pubmed : 28764981

 

46 - 

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment

Solene-Florence Kammerer-Jacquet, Angélique Brunot, Karim Bensalah, Boris Campillo-Gimenez, Mathilde Lefort et al.

Urologic Oncology: Seminars and Original Investigations, 2017, 35 (10), pp.603.e7 - 603.e14.

DOI : https://doi.org/10.1016/j.urolonc.2017.05.015

Pubmed : 28619630

 

47 - 

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

Solène-Florence Kammerer-Jacquet, Angélique Brunot, Adélaide Pladys, Guillaume Bouzille, Julien Dagher et al.

Clinical Genitourinary Cancer, 2017, 15 (1), pp.e1-e7.

DOI : https://doi.org/10.1016/j.clgc.2016.06.007

Pubmed : 27444986

 

48 - 

Hilar Fat Infiltration: An Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma with Sunitinib First-Line Treatment

Solène-Florence Kammerer-Jacquet, Angélique Brunot, Karim Benasalah, Boris Campillo-Gimenez, Mathilde Lefort et al.

Laboratory Investigation, 2017, 97, pp.234A--234A.

 

49 - 

Nomogram Predicting Prognosis in Metastatic Patients with Clear Cell Renal Cell Carcinoma Treated by First-Line Sunitinib

Solène-Florence Kammerer-Jacquet, Frédéric Dugay, Karim Bensalah, Angélique Brunot, Benoit Peyronnet et al.

Laboratory Investigation, 2017, 97, pp.234A--234A.

 

50 - 

Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential

Solène-Florence Kammerer-Jacquet, Laurence Crouzet, Angélique Brunot, Julien Dagher, Adélaide Pladys et al.

International Journal of Cancer, 2017, 140 (1), pp.142-148.

DOI : https://doi.org/10.1002/ijc.30429

Pubmed : 27623354